However, this hypothesis needs well-conducted large cohort and interventional studies to evaluate the morbidity of type 2 diabetes and the effect of CPAP treatment on INS sensitivity and glucose metabolism in women affected by both PCOS and OSAHS. The gene discussed is INS; the disease is polycystic ovary syndrome.